Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 3.3 to 2.3.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
C-Path from Diepenbeek, company number BE0762683482, closed financial year 2025 with a result of € -537,258 after tax. For that financial year C-Path recorded a gross margin of € 15,228 and equity of € -287,620. Compared with financial year 2024, the result moved from € -307,719 to € -537,258. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ -287,620
▲ € 321,428 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -537,258
▼ 75 % more loss than in 2024
Profit after tax over the fiscal year.
€ 15,590
▼ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.1 million.
People and assets in 2025
2.3
▼ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 173,227
▼ 9% vs 2024
€ 75,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,860
▲ 262% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 335,803
▼ 57% vs 2024
€ 117,829 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 155,451
▼ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 26,649
▲ 14% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 228,061 | € 180,416 | € 168,587 | € 15,228 | ▼ 91% |
| Profit after taxes | € -72,715 | € -240,475 | € -307,719 | € -537,258 | ▼ € 229,539 |
| Equity | € -60,853 | € -301,328 | € -609,047 | € -287,620 | ▲ € 321,428 |
| Total debts | € 601,063 | € 1,345,440 | € 1,547,415 | € 909,918 | ▼ 41% |
| Cash | € 9,963 | € 13,612 | € 26,796 | € 15,590 | ▼ 42% |
| Retained profit | € -61,853 | € -302,328 | € -610,047 | € -1,147,305 | ▼ € 537,258 |
| Bank debt | € 50,993 | € 815,201 | € 774,890 | € 335,803 | ▼ 57% |
| Balance sheet total | € 540,211 | € 1,044,112 | € 938,368 | € 622,298 | ▼ 34% |
| Employees (FTE) | 2.8 | 3.3 | 2.8 | 2.3 | ▼ 0.5 |
Key figures of C-Path, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to C-Path?
What happened at C-Path in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 537,258. Source: NBB ↗
- De Sasmeester CommV became a director. NBB
- Life Sciences Consulting bv stepped down as director. NBB
- New establishment in Diepenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 72,715 loss in 2022 to € 537,258 loss in 2025.
On average € 6,600 of value added per employee in 2025.
Management
Behind C-Path is De Sasmeester CommV. De Sasmeester CommV is also behind WAAROOST, IMAQUA, WAAROOST APOTHEEK, RUMEXPERTS and VETPHARM.
Directors
According to the 2025 annual accounts
Director · represented by Joris Pieter De Gussem
Also active at: WAAROOST, IMAQUA, WAAROOST APOTHEEK, RUMEXPERTS, VETPHARM, POULPHARM, MYVO
since 2025
· until 2025
Establishments
Establishment units
Physical locations of this company
Agoralaan Abis
3590 Diepenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Clinitude
€ 419,430 gross margin · 2025
FOx Biosystems
€ -763,895 gross margin · 2023
Highstar Engineering
€ -52,153 gross margin · 2025
IDEA FAMILY
€ -1,811 gross margin · 2026
BIOKEY
€ -16,079 gross margin · 2026
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0762.683.482
- VAT number
- BE 0762.683.482
- Registered office
- Agoralaan Abis, 3590 Diepenbeek
- Names & denominations
- C-Path
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 January 2021
- Peppol
- Active · Active since 15 Mar 2021
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Gegevensverwerking, webhosting en aanverwante activiteiten